
The Trump administration and Pfizer have made an agreement for the drug company to sell many medications to Medicaid at favored prices, along with offering some of its drugs for sale at lower prices on TrumpRx, per Forbes. However, the outlet noted that missing details make it tough to tell exactly how this program may impact struggling Americans and their budgets.
Read More: Trump Said He’d Lower Grocery Prices on Day 1: See Where They Stand Now